Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaideep Behari

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|July 19, 2025
Plant-based diet index and risk of hepatocellular carcinoma: Findings from a prospective cohort studyYen Thi-Hai Pham, Renwei Wang, Jaideep Behari, et al.
Journal of Hepatology|February 6, 2007
R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cellsJaideep Behari, Gang Zeng, Wade Otruba, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 15, 2021
Serum Biomarkers of Iron Status and Risk of Hepatocellular Carcinoma Development in Patients with Nonalcoholic Fatty Liver DiseaseYi-Chuan Yu, Hung N Luu, Renwei Wang, et al.
The American Journal of Pathology|December 19, 2009
Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitisJaideep Behari, Tzu-Hsuan Yeh, Lindsay Krauland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 16, 2013
Hepatic steatosis in diabetic patients does not predict adverse liver-related or cardiovascular outcomesMichael A Dunn, Jaideep Behari, Shari S Rogal, et al.
Plos One|June 4, 2014
Role of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinomaHirohisa Okabe, Evan Delgado, Jung Min Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 18, 2020
Serum IL27 in Relation to Risk of Hepatocellular Carcinoma in Two Nested Case-Control StudiesJian-Min Yuan, Yue Wang, Renwei Wang, et al.
Hepatology (Baltimore, Md.)|August 20, 2010
Liver-specific β-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasisTzu-Hsuan Yeh, Lindsay Krauland, Vijay Singh, et al.
Hepatology (Baltimore, Md.)|February 8, 2020
Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and FibrosisSudhir Kumar, Alok K Verma, Richa Rani, et al.
Cancers|June 2, 2021
Association between Pre-Diagnostic Serum Bile Acids and Hepatocellular Carcinoma: The Singapore Chinese Health StudyClaire E Thomas, Hung N Luu, Renwei Wang, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|July 19, 2025
Plant-based diet index and risk of hepatocellular carcinoma: Findings from a prospective cohort studyYen Thi-Hai Pham, Renwei Wang, Jaideep Behari, et al.
Journal of Hepatology|February 6, 2007
R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cellsJaideep Behari, Gang Zeng, Wade Otruba, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 15, 2021
Serum Biomarkers of Iron Status and Risk of Hepatocellular Carcinoma Development in Patients with Nonalcoholic Fatty Liver DiseaseYi-Chuan Yu, Hung N Luu, Renwei Wang, et al.
The American Journal of Pathology|December 19, 2009
Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitisJaideep Behari, Tzu-Hsuan Yeh, Lindsay Krauland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 16, 2013
Hepatic steatosis in diabetic patients does not predict adverse liver-related or cardiovascular outcomesMichael A Dunn, Jaideep Behari, Shari S Rogal, et al.
Plos One|June 4, 2014
Role of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinomaHirohisa Okabe, Evan Delgado, Jung Min Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 18, 2020
Serum IL27 in Relation to Risk of Hepatocellular Carcinoma in Two Nested Case-Control StudiesJian-Min Yuan, Yue Wang, Renwei Wang, et al.
Hepatology (Baltimore, Md.)|August 20, 2010
Liver-specific β-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasisTzu-Hsuan Yeh, Lindsay Krauland, Vijay Singh, et al.
Hepatology (Baltimore, Md.)|February 8, 2020
Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and FibrosisSudhir Kumar, Alok K Verma, Richa Rani, et al.
Cancers|June 2, 2021
Association between Pre-Diagnostic Serum Bile Acids and Hepatocellular Carcinoma: The Singapore Chinese Health StudyClaire E Thomas, Hung N Luu, Renwei Wang, et al.
Pageof 9